GlassScriptPhysician profile
Edward Reh
NPI 1124046354
$1,912.45
in general payments reported to CMS, 2019-2025
17 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $295 · 2021: $480 · 2022: $311 · 2023: $288 · 2024: $165 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $561.30 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $474.75 | 2019-2025 | |
| Glaxosmithkline, LLC. | $269.82 | 2019-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Exact Sciences Corporation | $97.37 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $78.21 | 2021 | |
| Almatica Pharma LLC | $71.39 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $70.96 | 2022-2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $44.38 | 2020-2022 | |
| Eisai INC. | $44.03 | 2020-2021 | |
| Sunovion Pharmaceuticals INC. | $40.44 | 2019-2021 | |
| Allergan, INC. | $37.06 | 2020 | |
| Sanofi-Aventis U.S. LLC | $33.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $22.57 | 2024 | Eliquis |
| Neurocrine Biosciences, INC. | $20.66 | 2024 | Ingrezza |
| Axsome Therapeutics, INC. | $17.26 | 2025 | Auvelity |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $14.81 | 2024 | Austedo Xr |
| Bausch Health US, LLC | $14.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Reh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.